Company Filing History:
1 out of 2 
1 out of 1 Years Active: 2013
Title: Maria Lamana Luzuriaga: Innovator in Stem Cell Therapy
Introduction
Maria Lamana Luzuriaga is a prominent inventor based in Madrid, Spain. She has made significant contributions to the field of stem cell therapy, particularly in the treatment of graft-versus-host disease (GVHD). Her innovative work has the potential to improve the lives of many patients undergoing allogeneic hematopoietic stem cell transplantation.
Latest Patents
Maria holds a patent for a method of treating graft-versus-host disease using adipose-derived mesenchymal stem cells. This invention relates to the use of a specific type of adipose tissue-derived mesenchymal stem cells (AD-MSCs), which possess immunosuppressive properties. The patent outlines the development of a pharmaceutical composition aimed at preventing and treating GVHD, a serious complication that can arise after stem cell transplants.
Career Highlights
Throughout her career, Maria has worked with notable organizations, including the Centro de Investigaciones Energéticas, Medioambientales y Tecnológicas and Tigenix, S.A. Her experience in these institutions has allowed her to advance her research and contribute to the scientific community.
Collaborations
Maria has collaborated with esteemed colleagues such as Manuel Angel González De La Peña and Dirk Büscher. These partnerships have enriched her research and fostered innovation in the field of stem cell therapy.
Conclusion
Maria Lamana Luzuriaga is a trailblazer in the realm of stem cell research, with her patent offering promising solutions for the treatment of graft-versus-host disease. Her work exemplifies the impact of innovative thinking in medicine and highlights the importance of collaboration in advancing scientific knowledge.